LIGAND PHARMACEUTICALS INC — Director's Dealing 2016

Aug 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2016-08-05

Reporting Person: FOEHR MATTHEW W (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-05	Common Stock	M	12500.0	$9.97	Acquired	91412	Direct
2016-08-05	Common Stock	S	12500.0	$122.14	Disposed	78912	Direct
2016-08-08	Common Stock	M	4125.0	$9.97	Acquired	83037	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-05	Employee Stock Option (right to buy)	$9.97	M	12500.0	Disposed	2021-04-18	Common Stock (12500)	Direct
2016-08-08	Employee Stock Option (right to buy)	$9.97	M	4125.0	Disposed	2021-04-18	Common Stock (4125)	Direct

Footnotes

F1: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 04/18/11.